JUAN JOSÉ
POZA ALDEA
Instituto de Investigación Sanitaria Biogipuzkoa
San Sebastián, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Biogipuzkoa (9)
2024
-
Dysregulated FOXO1 activity drives skeletal muscle intrinsic dysfunction in amyotrophic lateral sclerosis
Acta Neuropathologica, Vol. 148, Núm. 1
-
Further Evidence of Cerebellar Cognitive Affective/Schmahmann Syndrome in RFC1-Related Syndrome
Movement Disorders
2020
-
Phenotypic correlations in a large single-center cohort of patients with BSCL2 nerve disorders: a clinical, neurophysiological and muscle magnetic resonance imaging study
European Journal of Neurology, Vol. 27, Núm. 8, pp. 1364-1373
-
Targeted next-generation sequencing in a large cohort of genetically undiagnosed patients with neuromuscular disorders in Spain
Genes, Vol. 11, Núm. 5
2018
-
Clinical evidences supporting the Src/c-Abl pathway as potential therapeutic target in amyotrophic lateral sclerosis
Journal of the Neurological Sciences
2016
-
ALS: A bucket of genes, environment, metabolism and unknown ingredients
Progress in Neurobiology, Vol. 142, pp. 104-129
-
Cancer risk in DM1 is sex-related and linked to miRNA-200/141 downregulation
Neurology, Vol. 87, Núm. 12, pp. 1250-1257
-
Muscle imaging in muscle dystrophies produced by mutations in the EMD and LMNA genes
Neuromuscular Disorders, Vol. 26, Núm. 1, pp. 33-40
2011
-
Does the severity of the LGMD2A phenotype in compound heterozygotes depend on the combination of mutations?
Muscle and Nerve, Vol. 44, Núm. 5, pp. 710-714